Latest news releases from NIH-funded organizations
Funded Research News
Updates every hour. Last Updated: 24-Apr-2025 05:08 ET (24-Apr-2025 09:08 GMT/UTC)
Mass General Brigham researchers identify mutations that can lead to resistance to some chemotherapies
Mass General BrighamPeer-Reviewed Publication
Investigators at Mass General Brigham have uncovered how resistance to chemotherapies may occur in some cancers. Researchers focused on a pathway that harnesses reactive oxygen species (ROS) to kill cancer cells. The study found that mutations to VPS35, a key player in this pathway, can prevent chemotherapy-induced cell death. These results, published in Nature, could help pinpoint treatment-resistant tumors.
- Journal
- Nature
- Funder
- Damon Runyon Cancer Research Foundation, American Association for Cancer Research, American Cancer Society, The Krantz Family Center for Cancer Research Quantum Award, ), FujiFilm Therapeutics Graduate Program Fellowship, 412 post-baccalaureate fellowship from the UMass Boston-DF/HCC Partnership to Advance Cancer Health Equity, NIH/National Cancer Institute, Melanoma Research Alliance, the Ludwig Cancer Center of Harvard Medical School, LUNGevity Foundation, ALK Positive, V-Foundation, Mary Kay Foundation, Paula and Rodger Riney Foundation, PEW-Stewart Trusts, Lisa and Mark Schwartz, NIH/National Cancer Institute, DF/HCC SPORE in Gastrointestinal Cancer, NIH/National Cancer Institute
Drexel researchers develop new DNA test for personalized treatment of bacterial vaginosis
Drexel UniversityPeer-Reviewed Publication
Roughly one out of three women ages 14-49 in the United States develop a vaginal bacterial imbalance known as bacterial vaginosis (BV) during their lifetime. BV is characterized by unpleasant odors, and potentially painful side effects, as well as the risk of associated health issues later in life. More than half of the patients who seek medical care do not respond to the first-line treatment, the antibiotic metronidazole, leading to recurrence.
Now Drexel researchers have developed a simple DNA PCR-based lab test — built on a more detailed genetic analysis of the main group of bacterial organisms that cause the infection — to help clinicians prescribe the right medicine for each patient. The results are published this week in the journal Genome Medicine.
- Journal
- Genome Medicine
- Funder
- NIH/National Institutes of Health, NIH/National Institutes of Health
Meniscus injuries may soon be treated by customizable hydrogel
University of Pennsylvania School of MedicinePeer-Reviewed Publication
A new 3D printed customizable hydrogel performed well in preclinical trials with several different types of meniscal tears
- Journal
- Bioactive Materials
- Funder
- NIH/National Institutes of Health, U.S. National Science Foundation, Department of Veterans' Affairs, Korea Health Industry Development Institute, Ministry of Science and ICT
How a critical enzyme keeps potentially dangerous genes in check
La Jolla Institute for ImmunologyPeer-Reviewed Publication
- Journal
- Nature Structural & Molecular Biology
- Funder
- NIH/National Institutes of Health, National Health and Medical Research Council, Mater Foundation, Pew Charitable Trusts, California Institute for Regenerative Medicine